Targeting US$610 billion longevity market, biotech firms race to reverse ageing
Biotech companies are increasingly focusing on the longevity market, which is valued at approximately $610 billion. These firms are racing to develop technologies aimed at reversing the aging process. The competition is intensifying as advancements in biotechnology promise to extend human lifespan and improve health in later years.
- ▪The longevity market is estimated to be worth $610 billion.
- ▪Biotech firms are competing to create solutions that can reverse aging.
- ▪Advancements in biotechnology could lead to longer, healthier lives.
Opening excerpt (first ~120 words) tap to expand
.css-1e339y7{z-index:1400;}.css-1e339y7 .MuiDrawer-paper{overflow-y:hidden;}.css-1e339y7 .MuiDrawer-modal{background:rgba(0, 0, 0, 0.2);}.css-1h2k762{z-index:1200;z-index:1400;}.css-1h2k762 .MuiDrawer-paper{overflow-y:hidden;}.css-1h2k762 .MuiDrawer-modal{background:rgba(0, 0, 0, 0.2);}.css-1whztno{position:relative;}.css-1whztno:first-of-type .er6t7fe40>*:first-child{padding-block-start:0;}.css-ahnbry>*:first-child{padding-block:var(--mobile-widget-gap, 16px);}@media (min-width:768px){.css-ahnbry>*:first-child{padding-block:40px;}}.css-hhdj32{--content-tablet-up-max-inline-size:600px;--widget-extra-padding:12px;--mobile-widget-gap:16px;--desktop-widget-gap:18px;display:grid;grid:"header-container" min-content "leading" min-content "content-container" min-content "widgets-bottom"…
Excerpt limited to ~120 words for fair-use compliance. The full article is at South China Morning Post.